HLS Therapeutics Inc. (HLS.TO)
Sells medications for schizophrenia, depression, and heart disease across North America.
4.21+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-15.8%
The outlook
HLS.TO is trading below both its 50- and 200-day moving averages, placing it in the lower half of its 52-week range. Analyst targets average around 73% above the current price, suggesting a substantial gap between where the stock trades now and where coverage expects it could reach. Overall sentiment is neutral, with the stock showing modest volatility today.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range73% of the way from its 52-week low to high
Price targetAvg target +73% vs current price
Analyst price target
~12-month · 4 analysts7.30average target+73.4% vs now
Now 4.21
Low 4.60High 12.30
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$131.7M
52-wk high
5.77
52-wk low
0.00
50-day avg
4.35
200-day avg
4.66
Trailing P/E
—